Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ORAL TIPEPIDINE PREPARATION
Document Type and Number:
WIPO Patent Application WO/2017/209106
Kind Code:
A1
Abstract:
The present invention provides a novel oral composition of a single or twice daily dose type, which contains tipepidine or a pharmaceutically acceptable salt thereof, wherein the drug dissolution rate of tipepidine or the pharmaceutically acceptable salt thereof is controlled.

Inventors:
ESAKI NAOMI (JP)
KAWATA KYOKO (JP)
MORIZAKI KAZUKI (JP)
Application Number:
PCT/JP2017/020038
Publication Date:
December 07, 2017
Filing Date:
May 30, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAISHO PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K31/4535; A61K9/20; A61K47/32; A61K47/38; A61P11/10; A61P11/14; A61P13/00; A61P25/00; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28
Domestic Patent References:
WO2012118172A12012-09-07
Foreign References:
JPH1017497A1998-01-20
JPS6277335A1987-04-09
JPH05255125A1993-10-05
US5009895A1991-04-23
JP2007529551A2007-10-25
JP2015537030A2015-12-24
JP2013063958A2013-04-11
JP2011246446A2011-12-08
Other References:
CHILDRESS, A. ET AL.: "Current Investigational Drugs for the Treatment of Attention-Deficit/ Hyperactivity Disorder, ExpertOpin", INVESTIG. DRUGS, vol. 25, no. 4, April 2016 (2016-04-01), pages 463 - 474, XP055446037, ISSN: 1354-3784
Attorney, Agent or Firm:
ONO, SHINJIRO et al. (JP)
Download PDF: